Gsk Plc ADR (GSK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,942,279 | 5,506,606 | 5,571,966 | 4,939,970 | 6,209,536 |
| Marketable Securities | 177,208 | 225,926 | 317,285 | 188,165 | 320,754 |
| Receivables | 9,836,347 | 9,269,771 | 8,915,981 | 8,065,310 | 8,810,916 |
| Inventories | 7,541,764 | 8,088,423 | 7,875,064 | 7,161,862 | 7,411,381 |
| Other current assets | 198,052 | 106,154 | 173,954 | 145,633 | 362,643 |
| TOTAL | $22,695,650 | $23,196,880 | $22,854,250 | $20,500,940 | $23,115,230 |
| Non-Current Assets | |||||
| PPE Net | 14,232,670 | 14,730,100 | 14,835,850 | 13,996,370 | 13,920,720 |
| Investments And Advances | 2,169,495 | 1,776,105 | 1,608,690 | 1,429,279 | 1,461,067 |
| Intangibles | 30,113,634 | 31,400,988 | 31,855,112 | 30,023,889 | 31,008,399 |
| Other Non-Current Assets | 7,149,561 | 7,337,157 | 6,996,968 | 6,713,352 | 7,453,284 |
| TOTAL | $53,665,360 | $55,244,350 | $55,296,620 | $52,162,890 | $53,843,470 |
| Total Assets | $76,361,020 | $78,441,230 | $78,150,870 | $72,663,840 | $76,958,700 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 3,781,306 | 4,722,670 | 4,789,887 | 3,640,860 | 6,205,608 |
| Accounts payable and accrued liabilities | 17,060,180 | 17,073,740 | 29,346,060 | 27,026,140 | 25,974,530 |
| Accrued Expenses | 1,059,339 | 1,049,331 | 1,502,928 | 1,282,356 | 1,389,061 |
| Other current liabilities | 2,067,861 | 1,921,732 | 1,832,737 | 2,292,775 | 2,352,632 |
| TOTAL | $23,968,690 | $24,767,480 | $37,471,610 | $34,242,130 | $35,921,830 |
| Non-Current Liabilities | |||||
| Long Term Debt | 32,324,820 | 33,469,710 | 19,503,270 | 18,383,440 | 18,713,710 |
| Other Non-Current Liabilities | 13,500,389 | 14,391,212 | 13,836,357 | 13,500,550 | 13,253,029 |
| TOTAL | $47,541,260 | $49,559,450 | $35,683,410 | $33,925,080 | $34,714,750 |
| Total Liabilities | $71,509,950 | $74,326,930 | $73,155,020 | $68,167,210 | $70,636,580 |
| Shareholders' Equity | |||||
| Common Shares | 1,751,232 | 1,827,823 | 1,868,919 | 1,730,858 | 1,758,256 |
| Retained earnings | -2,711,543 | -3,647,480 | -8,840,835 | -8,347,558 | -7,002,911 |
| Other shareholders' equity | 1,838,533 | 1,793,798 | 7,751,212 | 7,222,436 | 7,624,781 |
| TOTAL | $4,851,069 | $4,114,303 | $4,995,844 | $4,496,623 | $6,322,127 |
| Total Liabilities And Equity | $76,361,019 | $78,441,233 | $78,150,864 | $72,663,833 | $76,958,707 |